Read articles from Global

April 24, 2025 by medicalxpress.com

Teens and young adults who used varenicline had over three times the success rate quitting vaping compared to those receiving counseling only, as per a Mass General Brigham study published in JAMA. Varenicline, proven effective for smoking cessation in adults, showed no participants returning to cigarettes. The study highlights the importance of medication in aiding young nicotine addicts, with varenicline offering a safe and effective solution for 16-to-25-year-olds looking to quit vaping. Research on alternative therapies and younger age groups is warranted. In addressing adolescent vaping addiction, varenicline emerged as a successful treatment avenue with no reported safety concerns.

April 23, 2025 by gfn.tv

In the second part of our science special, Roberto Sussman takes us through the fundamental physics of vape aerosols to help explain the difference between cigarette smoke and e-cigarette vapor!

April 23, 2025 by statnews.com

Sarah Todd resumed reporting in January 2025 after working as an assignment editor at STAT from October 2022. A recent study at Massachusetts General Hospital found that young e-cigarette users who took varenicline with counseling were more successful in quitting vaping compared to those on a placebo. The research, authored by Eden Evins, highlights the effectiveness of this approach for controlling nicotine cravings among youth. This could lead to a significant shift in how healthcare providers address nicotine addiction in young people, as varenicline has shown promise as a treatment option. Vaping remains a concern among adolescents and young adults due to its addictive nature and health risks associated with nicotine exposure.

April 22, 2025 by upi.com

Vaping addiction is mainly due to nicotine in e-cigarettes, not the flavors. However, flavors like menthol can increase usage frequency, especially among young people. Research shows that sweet flavors attract youth to vaping, contributing to nicotine dependence. Efforts have been made to regulate vaping products due to health concerns and their appeal to teens. The FDA oversees restrictions on sales and bans flavored products. Despite regulations, flavored e-cigarettes remain popular among teens. Manufacturers must consider the appeal of their products in addressing addiction issues and promoting public health.

April 22, 2025 by medicaldialogues.in

A study linked electronic cigarette use to a higher risk of chronic obstructive pulmonary disease (COPD). E-cigarettes simulate traditional cigarettes and may worsen respiratory conditions, affecting the efficacy of CPAP treatment for sleep apnea. The meta-analysis included 7 observational studies with over 35 million individuals, showing a 1.50-fold increased risk of COPD among e-cigarette users compared to non-users. Prospective cohort and cross-sectional studies revealed a 52% to 55% greater risk of COPD among e-cigarette users. This research highlights the potential negative impact of e-cigarette use on respiratory health, with implications for COPD prevention and management.

April 22, 2025 by daily-pouch.com

Tobacco control opposes nicotine pouches due to concerns about targeting children, but Philip Morris International's ZYN adopts responsible marketing practices, emphasizing safety for adult users. ZYN's strategy excludes influencers and celebrities, ensuring age-appropriate marketing. Although some critics suggest youth targeting through flavors and colors, ZYN's subdued branding defies this narrative. Grassroots enthusiasm and organic content differentiate ZYN's marketing approach, diverging from typical influencer strategies. Despite stringent age-gating measures and limited ad platforms, skepticism persists. The tension reflects broader societal mistrust and bias. ZYN's efforts to prevent underage use receive scrutiny from tobacco control, hinting at underlying motives in the anti-smoking agenda.

April 22, 2025 by gfn.tv

In 2016, PMI pledged to transition the company away from cigarette sales - and almost ten years later, they've made progress towards their promise. But instead of celebrating as 40% of PMI's business goes smoke-free, many in tobacco control would rather stand in the way. Why is that? And can anything be done to change their minds?

April 18, 2025 by edition.mv

The Ministry of Health is now accepting applications for the Tobacco Sales License, required under the Tobacco Control Act's recent amendment. A valid license from the Health Ministry is necessary for wholesale and retail sellers of tobacco products. Applications must be submitted within three months via the OneGov portal. Four licenses are needed for tobacco sales, each with a five-year validity and specific fees. Renewal applications should be made 60 days before the license expires. The fees range from MVR 5,000 for wholesale and retail to MVR 10,000 for import and re-export. Violations can result in fines from MVR 1,000 to MVR 1,000,000 and license revocation.

April 18, 2025 by vaping360.com

David Oliveira, a former FDA official, criticizes mismanagement under Brian King and FDA's focus on optics over public health. He opposes the Biden Administration's menthol cigarette ban as pushing people to the black market. Oliveira calls for aggressive enforcement against flavored disposables, targeting unauthorized vape shops to combat vaping, particularly criticizing Chinese manufacturers and obscure product flavors.

April 18, 2025 by clearingtheair.eu

Leading French oncologist Dr. David Khayat highlighted that nicotine alternatives like vapes do not cause cancer, as carcinogens in tobacco come from combustion. He stated that products like vapes reduce harmful substances and should be used more to aid smoking cessation, with harm reduction being crucial. Khayat emphasized the importance of regulatory frameworks balancing access and preventing youth uptake of these alternatives. With smoking causing eight million global deaths yearly, he urged smokers to consider safer alternatives. Khayat's views align with a cardiologist's stance on nicotine's non-carcinogenic and non-heart-disease-causing properties, pointing towards tobacco harm reduction discussions at an upcoming WHO conference.